A Study to Evaluate the Impact of Maintaining Hemoglobin Levels Using Epoetin Alfa in Patients With Metastatic Breast Cancer Receiving Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Anemia|Breast Neoplasms|Quality of Life
Interventions: DRUG: epoetin alfa
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.